Fibroblast Growth Factor Receptor 3 Mutations in Bladder Cancer: A Marker for Early-Stage Diagnosis
Background: Bladder cancer (BC) ranks as the tenth most common cancer globally, with a high recurrence rate. It is primarily caused by abnormalities in the epithelial layer lining the bladder and is classified from non-muscle invasive bladder cancer (NMIBC) to muscle-invasive bladder cancer (MI...
Saved in:
| Main Authors: | Hosam Elessawy, Omar F. Abdul‐Rasheed, Mohammed F. Alqanbar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
University of Baghdad/ Al-Kindy College of Medicine
2025-04-01
|
| Series: | مجله كليه طب الكندي |
| Subjects: | |
| Online Access: | https://jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/1855 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Towards Reliable Methodology: Microbiome Analysis of Fresh Frozen vs. Formalin-Fixed Paraffin-Embedded Bladder Tissue Samples: A Feasibility Study
by: Dominik Enderlin, et al.
Published: (2024-12-01) -
Droplet digital PCR assay for precise determination of FRS2 gene copy number in bladder cancer
by: Jinqian Li, et al.
Published: (2025-07-01) -
FGFR3 alterations in bladder cancer: Sensitivity and resistance to targeted therapies
by: Maxim Noeraparast, et al.
Published: (2024-10-01) -
Proteomic analysis reveals potential biomarker candidates in serous ovarian tumors – a preliminary study
by: Shona Pedersen, et al.
Published: (2025-04-01) -
Detection of fusion events by RNA sequencing in FFPE versus freshly frozen colorectal cancer tissue samples
by: Maxim Sorokin, et al.
Published: (2025-01-01)